Table 3.
Laboratory tests of AIIRD patients hospitalized for COVID-19.
| Variable * | 1st-3rd outbreaks, n=138 | 4th (Delta/vaccinated) outbreak |
|---|---|---|
| WBC 10e3/µL | 6 (4.25-10.17) | 4.8 (2.50-23.7) |
| Lymphocytes 10e3/µL n=136 | 0.8 (0.5-1.38) | 0.9 (0.4-2.5) |
| Hb g/dL | 12 (10.48-13.53) | 13.1 (7.2-15.9) |
| Platelets 10e3/µL n=137 | 203 (151-284) | 181 (34-249) |
| CRP mg/L n=134 | 11.75 (2.68-24) | 13 (0.05-150) |
| ALT U/L n=122 | 28.5 (18.75-52.75) | 29 (10-1036) |
| AST U/L n=113 | 32 (21-50) | 44 (17-3175) |
| Ferritin ng/mL n=70 | 374 (132.25-991.25) | 873 (124-4720) |
| D-dimer FEU n=89 | 0.93 (0.51-2.35) | 2.2 (0.5-80) |
| Triglycerides mg/dL n=40 | 107.5 (44-179) | 107.5 (82-286) |
| CPK U/L n=67 | 66 (37-138) | 129 (15-9700) |
*Variables are presented as median (IQR). AIIRD, autoimmune inflammatory rheumatic disease; COVID-19, coronavirus disease 2019; n, number; WBC, white blood cells; Hb, hemoglobin; CRP, C-reactive protein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CPK, creatine phosphokinase; IQR, interquartile range.